Cargando…

Qualitative evaluation of barriers and facilitators to hepatocellular carcinoma care in North Carolina

BACKGROUND: Many patients with hepatocellular carcinoma (HCC) never receive cancer-directed therapy. In order to tailor interventions to increase access to appropriate therapy, we sought to understand the barriers and facilitators to HCC care. METHODS: Patients with recently diagnosed HCC were ident...

Descripción completa

Detalles Bibliográficos
Autores principales: Ray, Emily M., Teal, Randall W., Carda-Auten, Jessica, Coffman, Erin, Sanoff, Hanna K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287003/
https://www.ncbi.nlm.nih.gov/pubmed/37347754
http://dx.doi.org/10.1371/journal.pone.0287338
_version_ 1785061852893413376
author Ray, Emily M.
Teal, Randall W.
Carda-Auten, Jessica
Coffman, Erin
Sanoff, Hanna K.
author_facet Ray, Emily M.
Teal, Randall W.
Carda-Auten, Jessica
Coffman, Erin
Sanoff, Hanna K.
author_sort Ray, Emily M.
collection PubMed
description BACKGROUND: Many patients with hepatocellular carcinoma (HCC) never receive cancer-directed therapy. In order to tailor interventions to increase access to appropriate therapy, we sought to understand the barriers and facilitators to HCC care. METHODS: Patients with recently diagnosed HCC were identified through the University of North Carolina (UNC) HCC clinic or local hospital cancer registrars (rapid case ascertainment, RCA). Two qualitative researchers conducted in-depth, semi-structured interviews. Interviews were audiotaped, transcribed, and coded. RESULTS: Nineteen interviews were conducted (10 UNC, 9 RCA). Key facilitators of care were: physician knowledge; effective communication regarding test results, plan of care, and prognosis; social support; and financial support. Barriers included: lack of transportation; cost of care; provider lack of knowledge about HCC; delays in scheduling; or poor communication with the medical team. Participants suggested better coordination of appointments and having a primary contact within the healthcare team. LIMITATIONS: We primarily captured the perspectives of those HCC patients who, despite the challenges they describe, were ultimately able to receive HCC care. CONCLUSIONS: This study identifies key facilitators and barriers to accessing care for HCC in North Carolina. Use of the RCA system to identify patients from a variety of settings, treated and untreated, enabled us to capture a broad range of perspectives. Reducing barriers through improving communication and care coordination, assisting with out-of-pocket costs, and engaging caregivers and other medical providers may improve access. This study should serve as the basis for tailored interventions aimed at improving access to appropriate, life-prolonging care for patients with HCC.
format Online
Article
Text
id pubmed-10287003
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-102870032023-06-23 Qualitative evaluation of barriers and facilitators to hepatocellular carcinoma care in North Carolina Ray, Emily M. Teal, Randall W. Carda-Auten, Jessica Coffman, Erin Sanoff, Hanna K. PLoS One Research Article BACKGROUND: Many patients with hepatocellular carcinoma (HCC) never receive cancer-directed therapy. In order to tailor interventions to increase access to appropriate therapy, we sought to understand the barriers and facilitators to HCC care. METHODS: Patients with recently diagnosed HCC were identified through the University of North Carolina (UNC) HCC clinic or local hospital cancer registrars (rapid case ascertainment, RCA). Two qualitative researchers conducted in-depth, semi-structured interviews. Interviews were audiotaped, transcribed, and coded. RESULTS: Nineteen interviews were conducted (10 UNC, 9 RCA). Key facilitators of care were: physician knowledge; effective communication regarding test results, plan of care, and prognosis; social support; and financial support. Barriers included: lack of transportation; cost of care; provider lack of knowledge about HCC; delays in scheduling; or poor communication with the medical team. Participants suggested better coordination of appointments and having a primary contact within the healthcare team. LIMITATIONS: We primarily captured the perspectives of those HCC patients who, despite the challenges they describe, were ultimately able to receive HCC care. CONCLUSIONS: This study identifies key facilitators and barriers to accessing care for HCC in North Carolina. Use of the RCA system to identify patients from a variety of settings, treated and untreated, enabled us to capture a broad range of perspectives. Reducing barriers through improving communication and care coordination, assisting with out-of-pocket costs, and engaging caregivers and other medical providers may improve access. This study should serve as the basis for tailored interventions aimed at improving access to appropriate, life-prolonging care for patients with HCC. Public Library of Science 2023-06-22 /pmc/articles/PMC10287003/ /pubmed/37347754 http://dx.doi.org/10.1371/journal.pone.0287338 Text en © 2023 Ray et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ray, Emily M.
Teal, Randall W.
Carda-Auten, Jessica
Coffman, Erin
Sanoff, Hanna K.
Qualitative evaluation of barriers and facilitators to hepatocellular carcinoma care in North Carolina
title Qualitative evaluation of barriers and facilitators to hepatocellular carcinoma care in North Carolina
title_full Qualitative evaluation of barriers and facilitators to hepatocellular carcinoma care in North Carolina
title_fullStr Qualitative evaluation of barriers and facilitators to hepatocellular carcinoma care in North Carolina
title_full_unstemmed Qualitative evaluation of barriers and facilitators to hepatocellular carcinoma care in North Carolina
title_short Qualitative evaluation of barriers and facilitators to hepatocellular carcinoma care in North Carolina
title_sort qualitative evaluation of barriers and facilitators to hepatocellular carcinoma care in north carolina
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287003/
https://www.ncbi.nlm.nih.gov/pubmed/37347754
http://dx.doi.org/10.1371/journal.pone.0287338
work_keys_str_mv AT rayemilym qualitativeevaluationofbarriersandfacilitatorstohepatocellularcarcinomacareinnorthcarolina
AT tealrandallw qualitativeevaluationofbarriersandfacilitatorstohepatocellularcarcinomacareinnorthcarolina
AT cardaautenjessica qualitativeevaluationofbarriersandfacilitatorstohepatocellularcarcinomacareinnorthcarolina
AT coffmanerin qualitativeevaluationofbarriersandfacilitatorstohepatocellularcarcinomacareinnorthcarolina
AT sanoffhannak qualitativeevaluationofbarriersandfacilitatorstohepatocellularcarcinomacareinnorthcarolina